IntroductionBlockade of the CD47/SIRPa axis has emerged as a promising approach to enhance macrophage-mediated anti-tumor activities in cancer immunotherapy. However, the clinical application of early
It is now widely known that C-X3-C motif ligand 1 (CX3CL1) plays an essential part in the process of regulating pro-inflammatory cells migration across a wide range of inflammatory disorders, includin
RNA-Sequencing of humanized mice bearing subcutaneous pancreatic tumors expressing either Ctrl shRNA or SDR16C5 shRNA received control PBS or PD-1 treatment.
